Hydrocortisone Arrow

Hydrocortisone Arrow is an oral medication that contains the glucocorticoid hydrocortisone; the specific strength and dosage form are not disclosed. It is marketed in the European Union and belongs to the corticosteroid therapeutic class. The product acts as an agonist of intracellular glucocorticoid receptors, providing anti‑inflammatory and immunosuppressive activity for a range of endocrine and autoimmune conditions.

Hydrocortisone Arrow is prescribed for conditions that require systemic glucocorticoid replacement or anti‑inflammatory therapy. It is commonly used in clinical practice for the following indications:

- Primary or secondary adrenal insufficiency (e.g., Addison's disease) - Congenital adrenal hyperplasia requiring hormone replacement - Inflammatory autoimmune disorders such as rheumatoid arthritis or systemic lupus erythematosus - Severe inflammatory bowel disease flares (e.g., ulcerative colitis) - Acute exacerbations of asthma or chronic obstructive pulmonary disease requiring systemic steroids

Adverse reactions to Hydrocortisone Arrow vary in frequency and severity. Patients should be aware of both common and serious potential effects.

Common: - Increased appetite and weight gain - Fluid retention leading to mild edema - Mild hyperglycemia or elevated blood glucose levels - Mood changes such as irritability or anxiety - Insomnia or sleep disturbances

Serious: - Suppression of the hypothalamic‑pituitary‑adrenal axis causing adrenal crisis on abrupt withdrawal - Increased susceptibility to severe infections - Osteoporosis or bone mineral density loss - Cushingoid appearance with facial rounding and central obesity - Significant hyperglycemia that may precipitate diabetes mellitus

Before initiating Hydrocortisone Arrow, clinicians should consider several safety factors to minimize risk.

- Evaluate baseline adrenal function and consider stress‑dose coverage during illness or surgery - Monitor blood glucose regularly, especially in patients with diabetes or metabolic syndrome - Avoid abrupt discontinuation; taper the dose gradually to prevent adrenal insufficiency - Use with caution in pregnant or breastfeeding individuals; assess risk‑benefit ratio - Screen for existing infections and defer use in uncontrolled systemic infections - Assess bone health periodically, particularly in long‑term therapy - Monitor intra‑ocular pressure in patients with glaucoma or a history of cataracts

Hydrocortisone Arrow can interact with several drug classes, affecting its efficacy or safety profile.

Avoid: - Strong CYP3A4 inducers such as rifampin or phenytoin, which may reduce hydrocortisone concentrations - Systemic antifungal agents like ketoconazole that can increase glucocorticoid levels and risk of toxicity - Live vaccines, as immunosuppression may diminish vaccine efficacy and increase infection risk

Use with caution: - Non‑steroidal anti‑inflammatory drugs (NSAIDs) due to heightened gastrointestinal bleeding risk - Anticoagulants (e.g., warfarin) because glucocorticoids may alter coagulation parameters - Diuretics, which can exacerbate fluid and electrolyte imbalances - Antidiabetic agents, as hydrocortisone may raise blood glucose and require dose adjustments - ACE inhibitors or ARBs, potentially increasing the risk of hypertension or fluid retention